Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.49 |
| ▸ | BTK | Q06187 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27793145 | 0.98 | HRH3 (0.47) | HRH3BTKADRB2ADRB1ADRB3 | |
| SCHEMBL31356450 | 0.98 | HRH3 (0.47) | HRH3BTKADRB2ADRB1ADRB3 | |
| SCHEMBL28655866 | 0.98 | HRH3 (0.47) | HRH3BTKADRB2ADRB1ADRB3 | |
| SCHEMBL11752523 | 0.98 | HRH3 (0.47) | HRH3BTKADRB2ADRB1ADRB3 | |
| SCHEMBL28172293 | 0.98 | HRH3 (0.47) | HRH3BTKADRB2ADRB1ADRB3 | |
| SCHEMBL1409272 | 0.98 | HRH3 (0.47) | HRH3BTKADRB2ADRB1ADRB3 | |
| SCHEMBL1690233 | 0.95 | HRH3 (0.49) | HRH3BTKADRB2ADRB1ADRB3 | |
| SCHEMBL186721 | 0.90 | HRH3 (0.51) | HRH3BTKSMN1; SMN2HSD17B10HPGD | |
| SCHEMBL1295721 | 0.90 | HRH3 (0.51) | HRH3BTKSMN1; SMN2HSD17B10HPGD | |
| SCHEMBL28492122 | 0.90 | HRH3 (0.51) | HRH3BTKSMN1; SMN2HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019055985-A1 | CLICK CHEMISTRY APTAMER TAGGING FOR EAB BIOSENSORS | ECCRINE SYSTEMS, INC. (US) | 2019-03-21 | — | — | WO | claimed |
| US-12037337-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-20240237518-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240218115-A1 | BRANCHED POLY(3-HYDROXYPROPIONIC ACID)POLYMER, AND METHOD FOR PREPARATION THEREOF | LG CHEM, LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD (KR) | 2024-06-27 | — | — | US | disclosed |
| US-12022730-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| CN-115010597-B | Synthesis method of cyclopentanecarboxylic acid | 湖北玖天生物医药科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| US-20240025840-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| US-20240023355-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| EP-0767794-B1 | PHOSPHINIC ACID DERIVATIVES | SCHERING CORP (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0933993-A1 | SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS INC. (US) | 1999-08-11 | — | — | EP | disclosed |
| CN-1222509-A | New pyrrole compounds, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1999-07-14 | — | — | CN | disclosed |
| WO-1997047194-A1 | SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 1997-12-18 | — | — | WO | disclosed |
| EP-0767794-A1 | PHOSPHINIC ACID DERIVATIVES | SCHERING CORPORATION (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1996000732-A9 | PHOSPHINIC ACID DERIVATIVES | — | 1996-02-22 | — | — | WO | disclosed |
| WO-1996000732-A1 | PHOSPHINIC ACID DERIVATIVES | SCHERING CORPORATION (US) | 1996-01-11 | — | — | WO | disclosed |
| US-5476847-A | Treating cardiovascular, gastrointestinal, urogenital disorders | SCHERING CORPORATION (US) | 1995-12-19 | — | — | US | disclosed |
| US-5407960-A | For cardiovascualr disorders, pain | SCHERING CORPORATION (US) | 1995-04-18 | — | — | US | disclosed |
| WO-1991009840-A1 | MERCAPTOCYCLOACYL AMINOACID ENDOPEPTIDASE INHIBITORS | SCHERING CORPORATION (US) | 1991-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023355-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CRY2, CYP1A1 | HRH3 4489/4885BTK 1539/4885ADRB2 780/4885 |
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CCNL2, UBE2L3 | HRH3 624/4885BTK 1676/4885ADRB2 1163/4885 |
| US-12037337-B2 | Compound and organic light emitting device comprising the same | CRY1, CRY2, C1S | HRH3 183/4885BTK 3119/4885ADRB2 298/4885 |
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, AHR | HRH3 610/4885BTK 3144/4885ADRB2 72/4885 |
| US-12022730-B2 | Compound and organic light emitting device comprising the same | CRY1, ARRB1, CYP1A1 | HRH3 216/4885BTK 4011/4885ADRB2 452/4885 |
| US-20240025840-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, TMEM109 | HRH3 3233/4885BTK 2168/4885ADRB2 2164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.